Royal Bank of Canada Lowers Danaher (NYSE:DHR) Price Target to $311.00

Danaher (NYSE:DHR) had its price objective decreased by Royal Bank of Canada from $333.00 to $311.00 in a research note published on Wednesday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the conglomerate’s stock.

Other research analysts have also issued research reports about the stock. Raymond James lowered their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday. Wells Fargo & Company assumed coverage on shares of Danaher in a report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target for the company. KeyCorp raised their price target on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday. Stephens restated an “overweight” rating and set a $315.00 price target on shares of Danaher in a report on Wednesday. Finally, Stifel Nicolaus raised their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $287.28.

Danaher Stock Down 1.1 %

Shares of NYSE DHR opened at $245.39 on Wednesday. The company has a 50 day simple moving average of $269.52 and a 200 day simple moving average of $260.42. The firm has a market cap of $181.76 billion, a PE ratio of 41.59, a price-to-earnings-growth ratio of 4.49 and a beta of 0.83. Danaher has a 1 year low of $182.09 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the business earned $2.02 EPS. On average, research analysts forecast that Danaher will post 7.59 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher’s payout ratio is currently 18.31%.

Insider Activity at Danaher

In related news, CEO Rainer Blair sold 9,007 shares of Danaher stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total value of $2,521,960.00. Following the completion of the sale, the chief executive officer now owns 97,983 shares of the company’s stock, valued at approximately $27,435,240. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Danaher news, CEO Rainer Blair sold 9,007 shares of Danaher stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the transaction, the chief executive officer now directly owns 97,983 shares of the company’s stock, valued at $27,435,240. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Matthew Mcgrew sold 16,172 shares of Danaher stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $279.84, for a total transaction of $4,525,572.48. Following the transaction, the chief financial officer now directly owns 29,407 shares in the company, valued at $8,229,254.88. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 30,059 shares of company stock valued at $8,400,897. 11.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On Danaher

A number of hedge funds have recently bought and sold shares of DHR. Tsfg LLC raised its stake in shares of Danaher by 733.3% during the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 88 shares during the period. nVerses Capital LLC bought a new stake in shares of Danaher during the 2nd quarter worth $25,000. CarsonAllaria Wealth Management Ltd. bought a new stake in shares of Danaher during the 2nd quarter worth $25,000. Redmont Wealth Advisors LLC bought a new stake in shares of Danaher during the 1st quarter worth $30,000. Finally, MFA Wealth Advisors LLC bought a new stake in shares of Danaher during the 2nd quarter worth $51,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.